Drug Shortage Report for AVELOX I.V.
Report ID | 12543 |
Drug Identification Number | 02246414 |
Brand name | AVELOX I.V. |
Common or Proper name | moxifloxacin injection |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MOXIFLOXACIN |
Strength(s) | 400MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250 mL Ready-to-use minibag |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-06-30 |
Actual start date | |
Estimated end date | 2018-03-29 |
Actual end date | 2018-02-23 |
Shortage status | Resolved |
Updated date | 2018-02-27 |
Company comments | Avelox I.V. is now in bottle and available to the market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-12 | English | Compare |
v2 | 2017-06-12 | French | Compare |
v3 | 2017-07-01 | English | Compare |
v4 | 2018-02-27 | English | Compare |
v5 | 2018-02-27 | French | Compare |
v6 | 2018-02-27 | English | Compare |
v7 | 2018-02-27 | French | Compare |
Showing 1 to 7 of 7